AR018898A1 - DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT - Google Patents

DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Info

Publication number
AR018898A1
AR018898A1 ARP990102951A AR018898A1 AR 018898 A1 AR018898 A1 AR 018898A1 AR P990102951 A ARP990102951 A AR P990102951A AR 018898 A1 AR018898 A1 AR 018898A1
Authority
AR
Argentina
Prior art keywords
tiazolidindiona
aril
derivatives
manufacture
pharmaceutical composition
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to ARP990102951 priority Critical patent/AR018898A1/en
Publication of AR018898A1 publication Critical patent/AR018898A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Las 5-aril-2,4-tiazolidindionas son potentes agonistas de PPAR y, por lo tanto, son utiles en el tratamiento, control o prevencion de la diabetes,hiperglicemia, hiperlipidemia (incluyendo hipercolesterolemia e hipertrigliceridemia), aterosclerosis, obesidad, restenosis vascular y otras enfermedades,desordenes y condiciones mediadas por PPAR, alfa, delta y/o gama.5-Aryl-2,4-thiazolidinediones are potent agonists of PPAR and, therefore, are useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis and other diseases, disorders and conditions mediated by PPAR, alpha, delta and / or range.

ARP990102951 1999-06-18 1999-06-18 DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AR018898A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP990102951 AR018898A1 (en) 1999-06-18 1999-06-18 DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP990102951 AR018898A1 (en) 1999-06-18 1999-06-18 DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Publications (1)

Publication Number Publication Date
AR018898A1 true AR018898A1 (en) 2001-12-12

Family

ID=45606563

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102951 AR018898A1 (en) 1999-06-18 1999-06-18 DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Country Status (1)

Country Link
AR (1) AR018898A1 (en)

Similar Documents

Publication Publication Date Title
WO2002026729A3 (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
WO2002060434A3 (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
ATE333448T1 (en) ARYLTHIAZOLIDINEDIONE AND ARYLOXA ZOLIDINEDIONE DERIVATIVES
WO2002064094A3 (en) 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
ATE352545T1 (en) ARYLTHIAZOLIDINDONE DERIVATIVES
DE60044041D1 (en) Exendine for glucagon suppression
WO2002060388A3 (en) Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
NO20015607D0 (en) Glukagonantagonister / inversagonister
BR9707325A (en) Process for the treatment of an affected patient with an il-1-mediated disease, pharmaceutical composition and use
BR0115531A (en) Mucositis treatment
BR0209468A (en) Pharmaceutically acceptable compound or salts or solvates thereof, pharmaceutical composition, use of a compound, and method of treating an HPP-mediated disease or condition
ES2102391T3 (en) DISPOSABLE SANITARY ITEMS.
UY27455A1 (en) DERIVATIVES N- (1,4,5,6-TETRAHIDRO-CICLOPENTAPIRAZOL -3-IL) - REPLACED. ITS OBTAINING AND USE AS DRUGS.
BR0107628A (en) 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation
AR018898A1 (en) DERIVATIVES OF 5-ARIL-2,4-TIAZOLIDINDIONA, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
DK0479093T3 (en) Oligosaccharide derivatives and their use as drugs
NO975636L (en) Pharmaceutical composition for promoting osteogenesis
PA8531601A1 (en) NEW HETEROAROMATOS
DOP2001000256A (en) DERIVATIVES OF ACIDOBENZOPIRANCARBOXILICO FOR THE TREATMENT OF DIABETES AND LIPID DISORDERS.
IT1289154B1 (en) ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE
ECSP993022A (en) ARILTIAZOLIDINDIONA DERIVATIVES
CL2004001291A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES CARBOCICLIC AND HETEROCICLIC COMPOUNDS; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF INFLUENZA INFECTION.
ES2049711T1 (en) USE OF BUCILAMINE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CYSTINURIA.
DK0538690T3 (en) Arylquinolyl-substituted 1,4-dihydropyridine-dicarboxylic acid derivatives, process for their preparation in drug use
ES2055421T3 (en) USE OF CLORMETIAZOLE IN THE MANUFACTURE OF A MEDICATION FOR THE PREVENTION AND / OR TREATMENT OF NEURODEGENERATION.